BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2004
View Archived Issues
Utility of pramlintide demonstrated in recent diabetes trials
Read More
AstraZeneca claims three novel series of delta opioid agonists
Read More
New RUP3 receptor modulators and their use claimed by Arena
Read More
Novel CHK1 kinase inhibitors identified by Pfizer team
Read More
Pharmacopeia researchers describe new IL-8 receptor inhibitors
Read More
New c-Kit inhibitors under study at OSI
Read More
New peptides targeting tumor cells and their use claimed by Attenuon
Read More
CAT-354 to enter phase I study in U.K.
Read More
Graffinity Pharmaceuticals and MyoContract merge to form Santhera
Read More
Nucryst reports phase IIa results for NPI-32101 in atopic dermatitis
Read More
Aeolus cleared to begin phase I trials of AEOL-10150
Read More
Canadian approval for phase IIa study of MBI-3253
Read More
Subsequent offering period expires in Sanofi-Aventis offer for Aventis
Read More
U.S./Canadian pivotal study commences for icatibant in hereditary angioedema
Read More
New study evaluates effects of HCT-3012 vs. rofecoxib on blood pressure
Read More
Antineoplastons A10 and AS2-1 gain orphan drug status for brain stem glioma
Read More
Cellegesic NDA accepted for review
Read More
Avexa demerger approval
Read More
Pain Therapeutics completes enrollment in first phase III study of Oxytrex
Read More
Callisto licenses annamycin from M.D. Anderson
Read More
Toyama Chemical and GSK collaborate in antibacterial development
Read More
Glenmark files to advance GRC-3886 into phase I studies in U.K.
Read More
Clinical evidence supports the antidiabetic efficacy of MK-0431 in humans
Read More
Good safety profile found for EM-1421 in refractory head and neck cancer
Read More
Sitaxsentan improves performance of PAH patients failing bosentan therapy
Read More
L-2264 improves hyperglycemia, lipids in animal model of diabetes
Read More
CollaGenex highlights Q2 progress
Read More
Antigenics continued steady progress during second quarter
Read More
FR-183998 shows beneficial effects in porcine pancreas allotransplantation model
Read More
New, potent alphavbeta3 antagonists selected for clinical evaluation for osteoporosis at Merck
Read More